GI & Endoscopy

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 21 to Aug. 25.

RealTime Dynamix analysts believe gastroenterologists and payers may thwart the widespread adaptation of biosimilars.

The FDA approved Cyltezo, a second biosimilar for AbbVie's Humira, Medscape reports.

Brian Liem, DO, joined the staff of Maywood, Ill.-based Loyola Medicine, the Chicago Tribune reports.

Houston-based Baylor College of Medicine gastroenterology division physicians Avi Ketwaroo, MD, Richa Shukla, MD, Yamini Natarajan, MD and Jordan Shapiro, MD, met with U.S. Rep. Gene Green, D-Texas.

Endoscopy Center I is the endoscopy center of Austin (Texas) Gastroenterology.

Eduardo Alcocer, MD, is a gastroenterologist at Austin (Texas) Gastroenterology.

AzurRx BioPharma enrolled a sixth patient into its phase IIa trial for MS1819, a treatment for exocrine pancreatic insufficiency associated with chronic pancreatitis.

The Cancer Prevention and Research Institute of Texas awarded Navkiran Shokar, MD, $3.7 million to study colorectal cancer, El Paso Inc. reports.

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Aug. 21 to Aug. 25, 2017.